Loading…
Trinex Pharmacy's website was found to illegally sell unapproved and misbranded opioid and Schedule II stimulant drugs directly to U.S. consumers via the internet, violating the Federal Food, Drug, and Cosmetic Act sections 301(a), 301(d), 301(k), 503(b), and 505(a). The company's operations posed significant public health risks by making these controlled substances easily accessible online without proper FDA approval or legitimate prescription verification, particularly concerning given the ongoing opioid epidemic and the high abuse potential of Schedule II stimulants among young adults. The FDA emphasized that unapproved drugs lack the safety and effectiveness assurances required for legal distribution, and that internet diversion of these drugs directly contributed to prescription drug abuse, addiction, and overdose mortality.